IBDEI1FF ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25571,0)
 ;;=338.19^^145^1542^26
 ;;^UTILITY(U,$J,358.3,25571,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25571,1,4,0)
 ;;=4^338.19
 ;;^UTILITY(U,$J,358.3,25571,1,5,0)
 ;;=5^Other Acute Pain
 ;;^UTILITY(U,$J,358.3,25571,2)
 ;;=^334073
 ;;^UTILITY(U,$J,358.3,25572,0)
 ;;=338.21^^145^1542^12
 ;;^UTILITY(U,$J,358.3,25572,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25572,1,4,0)
 ;;=4^338.21
 ;;^UTILITY(U,$J,358.3,25572,1,5,0)
 ;;=5^Chronic Pain due to Trauma
 ;;^UTILITY(U,$J,358.3,25572,2)
 ;;=^334074
 ;;^UTILITY(U,$J,358.3,25573,0)
 ;;=338.22^^145^1542^13
 ;;^UTILITY(U,$J,358.3,25573,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25573,1,4,0)
 ;;=4^338.22
 ;;^UTILITY(U,$J,358.3,25573,1,5,0)
 ;;=5^Chronic Post-Thoracotomy Pain
 ;;^UTILITY(U,$J,358.3,25573,2)
 ;;=^334075
 ;;^UTILITY(U,$J,358.3,25574,0)
 ;;=338.28^^145^1542^28
 ;;^UTILITY(U,$J,358.3,25574,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25574,1,4,0)
 ;;=4^338.28
 ;;^UTILITY(U,$J,358.3,25574,1,5,0)
 ;;=5^Other Chronic Postop Pain
 ;;^UTILITY(U,$J,358.3,25574,2)
 ;;=^334076
 ;;^UTILITY(U,$J,358.3,25575,0)
 ;;=338.29^^145^1542^27
 ;;^UTILITY(U,$J,358.3,25575,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25575,1,4,0)
 ;;=4^338.29
 ;;^UTILITY(U,$J,358.3,25575,1,5,0)
 ;;=5^Other Chronic Pain
 ;;^UTILITY(U,$J,358.3,25575,2)
 ;;=^334077
 ;;^UTILITY(U,$J,358.3,25576,0)
 ;;=338.3^^145^1542^8
 ;;^UTILITY(U,$J,358.3,25576,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25576,1,4,0)
 ;;=4^338.3
 ;;^UTILITY(U,$J,358.3,25576,1,5,0)
 ;;=5^Cancer Associated Pain
 ;;^UTILITY(U,$J,358.3,25576,2)
 ;;=^334078
 ;;^UTILITY(U,$J,358.3,25577,0)
 ;;=338.4^^145^1542^11
 ;;^UTILITY(U,$J,358.3,25577,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25577,1,4,0)
 ;;=4^338.4
 ;;^UTILITY(U,$J,358.3,25577,1,5,0)
 ;;=5^Chronic Pain Syndrome
 ;;^UTILITY(U,$J,358.3,25577,2)
 ;;=^334079
 ;;^UTILITY(U,$J,358.3,25578,0)
 ;;=780.96^^145^1542^17
 ;;^UTILITY(U,$J,358.3,25578,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25578,1,4,0)
 ;;=4^780.96
 ;;^UTILITY(U,$J,358.3,25578,1,5,0)
 ;;=5^Generalized Pain
 ;;^UTILITY(U,$J,358.3,25578,2)
 ;;=^334163
 ;;^UTILITY(U,$J,358.3,25579,0)
 ;;=607.9^^145^1542^30
 ;;^UTILITY(U,$J,358.3,25579,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25579,1,4,0)
 ;;=4^607.9
 ;;^UTILITY(U,$J,358.3,25579,1,5,0)
 ;;=5^Penile Pain
 ;;^UTILITY(U,$J,358.3,25579,2)
 ;;=^270442
 ;;^UTILITY(U,$J,358.3,25580,0)
 ;;=608.9^^145^1542^32
 ;;^UTILITY(U,$J,358.3,25580,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25580,1,4,0)
 ;;=4^608.9
 ;;^UTILITY(U,$J,358.3,25580,1,5,0)
 ;;=5^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,25580,2)
 ;;=^123856
 ;;^UTILITY(U,$J,358.3,25581,0)
 ;;=V68.1^^145^1543^4
 ;;^UTILITY(U,$J,358.3,25581,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25581,1,4,0)
 ;;=4^V68.1
 ;;^UTILITY(U,$J,358.3,25581,1,5,0)
 ;;=5^Rx Refill (Also mark Condition)
 ;;^UTILITY(U,$J,358.3,25581,2)
 ;;=RX Refill (also mark Condition)^295585
 ;;^UTILITY(U,$J,358.3,25582,0)
 ;;=V68.81^^145^1543^6
 ;;^UTILITY(U,$J,358.3,25582,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25582,1,4,0)
 ;;=4^V68.81
 ;;^UTILITY(U,$J,358.3,25582,1,5,0)
 ;;=5^Transfer of Care (Also Mark Dx)
 ;;^UTILITY(U,$J,358.3,25582,2)
 ;;=Transfer of Care ^295587
 ;;^UTILITY(U,$J,358.3,25583,0)
 ;;=V58.83^^145^1543^5
 ;;^UTILITY(U,$J,358.3,25583,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25583,1,4,0)
 ;;=4^V58.83
 ;;^UTILITY(U,$J,358.3,25583,1,5,0)
 ;;=5^Therapeutic Drug Monitoring
 ;;^UTILITY(U,$J,358.3,25583,2)
 ;;=Encounter for Therapeutic Drug Monitoring^322076
 ;;^UTILITY(U,$J,358.3,25584,0)
 ;;=V65.19^^145^1543^3
